SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-004958
Filing Date
2022-01-18
Accepted
2022-01-18 17:00:38
Documents
2
Period of Report
2022-01-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm223246-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm223246-1_4seq1.xml 4 11491
2 EXHIBIT 24 tm223246d1_ex24.htm EX-24 8466
  Complete submission text file 0001104659-22-004958.txt   21466
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Issuer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 405 WEST 14TH STREET C/O CAPSTAR SPECIAL PURPOSE ACQUISITION CORP AUSTIN TX 78701
Business Address
Cavanaugh Kathryn (Reporting) CIK: 0001815629 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39362 | Film No.: 22535814